Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Fish and Richardson
UBS
Johnson and Johnson
US Department of Justice
Farmers Insurance

Generated: July 17, 2019

DrugPatentWatch Database Preview

Patent: 8,821,865

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,821,865
Title:High concentration anti-TNF.alpha. antibody liquid formulations
Abstract: The invention provides a liquid aqueous pharmaceutical formulation comprising a human anti-TNFa antibody, or antigen-binding portion thereof, which reduces pain associated with injection in a subject by at least about 50% when compared to injecting an otherwise identical formulation comprising at least one salt and/or at least one buffer. The invention also provides a liquid aqueous pharmaceutical formulation comprising a human anti-TNFa antibody, or antigen-binding portion thereof, having increased bioavailability upon subcutaneous administration into a subject. The formulation may comprise a therapeutic protein, such as a human anti-TNF-alpha antibody, or an antigen-binding portion thereof, or a biosimilar thereof.
Inventor(s): Neu; Michael (Edingen-Neckarahuasen, DE), Tschoepe; Markus (Hessheim, DE), Weber; Carsten (Maxdorf, DE), Fraunhofer; Wolfgang (Gurnee, IL), Redden; Laura (Glenview, IL), Gastens; Martin (Wachenheim, DE), Feick; Alexander (Allschwil, CH)
Assignee: Abbvie Biotechnology Ltd. (Hamilton, BM)
Application Number:13/294,692
Patent Claims:see list of patent claims

Details for Patent 8,821,865

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Abbvie Inc HUMIRA adalimumab VIAL 125057 002 2002-12-31 ➤ Sign Up Abbvie Biotechnology Ltd. (Hamilton, BM) ➤ Sign Up RX search
Abbvie Inc HUMIRA adalimumab SYRINGE 125057 001 2002-12-31 ➤ Sign Up Abbvie Biotechnology Ltd. (Hamilton, BM) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Daiichi Sankyo
Queensland Health
US Department of Justice
QuintilesIMS
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.